Data-Driven Insights
Branded Pharma Fees
July 2, 2014 | racadmin
[blockquote author=”” link=”” target=”_blank”]Branded Pharma Fee: We received our 2014 Branded Rx Drug Fee this week and it was a decent amount higher than expected. This was driven by our share of government sales going up and the denominator (Total Industry Government Sales) actually went down a little vs prior year – first time this has happened. Are other companies seeing the same data trends and denominator decline? Was anyone ‘spot-on’ there forecast and have insight/best practices on forecasting pharma fee?[/blockquote]
Lorem ipsum dolor sit amet, consectetur adipiscing elit. Nulla semper leo viverra mi sollicitudin, sed gravida tortor molestie. Nulla imperdiet, nisi id porta venenatis, nisi leo lacinia nisi, et porttitor justo diam at elit. Duis gravida, neque et viverra interdum, dolor est consectetur massa, vel fermentum ipsum dui sit amet ligula. Etiam tristique neque vitae nibh tempus ultrices. Quisque vehicula, nisi ut vulputate porta, ligula diam lacinia ligula, ut elementum turpis sapien at massa. Aenean tempor eget lorem ac fermentum. Pellentesque blandit nibh interdum tellus consequat, non mollis lacus porta. In hac habitasse platea dictumst. Etiam augue magna, mollis eget eleifend in, facilisis a risus. Cum sociis natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus.